424 results on '"Callegaro, Dagoberto"'
Search Results
102. Voiding dysfunction in patients with neuromyelitis optica spectrum disorders
103. Oral fingolimod to treat multiple sclerosis: see your cardiologist first
104. Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
105. Neuromyelitis Optica Spectrum with Autoantibodies Against Myelin-Oligodendrocyte Glycoprotein Have Distinct Clinical Features and Prognosis from Seronegative Patients (S63.006)
106. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
107. Spinal cord tumor in a patient with multiple sclerosis: case report
108. Spinal cord tumor in a patient with multiple sclerosis: case report
109. Ressonância magnética em cinco pacientes com lesões desmielinizantes pseudo-tumorais do sistema nervoso central
110. Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations
111. Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid
112. Differential Diagnosis of Longitudinally Extensive Transverse Myelitis (P02.109)
113. Clinical Course of LETM Associated with Neuroschistosomiasis (P03.253)
114. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
115. A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
116. Voiding Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorders.
117. Creutzfeldt-Jakob disease: a survey of 14 patients
118. The expanded spectrum of neuromyelitis optica: evidences for a new definition
119. Quantification of Retinal Neural Loss in Patients with Neuromyelitis Optica and Multiple Sclerosis with or without Optic Neuritis Using Fourier-Domain Optical Coherence Tomography
120. Comparison of Visual Acuity and Automated Perimetry Findings in Patients With Neuromyelitis Optica or Multiple Sclerosis After Single or Multiple Attacks of Optic Neuritis
121. 1664 IMPACT OF DETRUSOR SPHINCTER DYSSYNERGIA ON CLINICAL AND URODYNAMIC PARAMETERS OF PATIENTS WITH NEUROMYELITIS OPTICA
122. Treatment of neuromyelitis optica: an evidence based review
123. 1509 VOIDING DYSFUNCTION IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDERS
124. Optical coherence tomography evaluation of retinal nerve fiber layer in longitudinally extensive transverse myelitis
125. Corpus Callosum Microstructural Changes Correlate with Cognitive Dysfunction in Early Stages of Relapsing-Remitting Multiple Sclerosis: Axial and Radial Diffusivities Approach
126. Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits
127. Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of São Paulo
128. Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica
129. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test
130. Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors
131. Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
132. Recurrent neuromyelitis optica with diffuse central nervous system involvement: case report
133. Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: I. As evidências para o uso de imunossupressores, plasmaférese e transplante autólogo de células tronco
134. Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: II. As evidências para o uso de glicocorticóides e imunomoduladores
135. Spinal cord tumor in a patient with multiple sclerosis: case report
136. Aspectos históricos de la esclerosis múltiple
137. Amyotrophic lateral sclerosis in Brazil: 1998 national survey
138. Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients.
139. Pathologic yawning in neuromyelitis optica spectrum disorders.
140. Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis.
141. Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations.
142. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
143. Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD
144. Creutzfeldt-Jakob disease: a survey of 14 patients
145. Tongue forces and handgrip strength in normal individuals: association with swallowing
146. Pediatric multiple sclerosis report of 14 cases
147. Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
148. Season of birth as a risk factor for multiple sclerosis in Brazil.
149. Pediatric multiple sclerosis: Evaluation of laboratory, neuroimaging, and neurophysiologic procedures: Report of 14 cases
150. Pediatric multiple sclerosis: Clinical aspects. Report of 14 cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.